NRX Pharmaceuticals:在2026年11月10日GDUFA目标日期到来之前,所有被要求做出的变更均已被归类为“轻微”。
NRX Pharmaceuticals:在2026年11月10日GDUFA目标日期到来之前,所有被要求做出的变更均已被归类为“轻微”。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.